These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 34737577)

  • 1. Identification of HOXD10 as a Marker of Poor Prognosis in Glioblastoma Multiforme.
    Li Y; Ma K; Xie Q; Zhang X; Zhang X; Chen K; Kong L; Qian R
    Onco Targets Ther; 2021; 14():5183-5195. PubMed ID: 34737577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of lncRNA-associated ceRNA networks to identify prognostic lncRNA biomarkers for glioblastoma.
    Liu Z; Wang X; Yang G; Zhong C; Zhang R; Ye J; Zhong Y; Hu J; Ozal B; Zhao S
    J Cell Biochem; 2020 Jul; 121(7):3502-3515. PubMed ID: 32277520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of an immune-related gene signature for the prognosis and diagnosis of glioblastoma multiforme.
    Yu Z; Yang H; Song K; Fu P; Shen J; Xu M; Xu H
    Front Oncol; 2022; 12():938679. PubMed ID: 35982954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic analysis of the long noncoding RNA (lncRNA)-miRNA-mRNA competing endogenous RNA network to identify prognostic biomarkers and the potential regulatory axis in glioblastoma multiforme.
    Li X; Chen R; Ren C; Huang A; Ding W; Wang H
    Transl Cancer Res; 2021 Nov; 10(11):4739-4755. PubMed ID: 35116328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients.
    Gao WZ; Guo LM; Xu TQ; Yin YH; Jia F
    J Transl Med; 2018 Dec; 16(1):368. PubMed ID: 30572911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analyzing the lncRNA, miRNA, and mRNA-associated ceRNA networks to reveal potential prognostic biomarkers for glioblastoma multiforme.
    Zhu X; Jiang L; Yang H; Chen T; Wu X; Lv K
    Cancer Cell Int; 2020; 20():393. PubMed ID: 32821246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of biomarkers and ceRNA network in glioblastoma through bioinformatic analysis and evaluation of potential prognostic values.
    Hong F; Gong Z; Zhang X; Ma P; Yin Y; Wang H
    Ann Transl Med; 2021 Oct; 9(20):1561. PubMed ID: 34790767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a 3 RNA Binding Protein Signature for Predicting Prognosis and Treatment Response for Glioblastoma Multiforme.
    Sun R; Pan Y; Mu L; Ma Y; Shen H; Long Y
    Front Genet; 2021; 12():768930. PubMed ID: 34733320
    [No Abstract]   [Full Text] [Related]  

  • 9. Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme.
    Yang J; Wang L; Xu Z; Wu L; Liu B; Wang J; Tian D; Xiong X; Chen Q
    Front Genet; 2020; 11():253. PubMed ID: 32296458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma.
    Yu W; Ma Y; Hou W; Wang F; Cheng W; Qiu F; Wu P; Zhang G
    Front Immunol; 2021; 12():706936. PubMed ID: 34899682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Hub Gene GRIN1 Correlated with Histological Grade and Prognosis of Glioma by Weighted Gene Coexpression Network Analysis.
    Yang A; Wang X; Hu Y; Shang C; Hong Y
    Biomed Res Int; 2021; 2021():4542995. PubMed ID: 34840971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction and analysis of hub genes between glioblastoma and low-grade glioma using bioinformatics analysis.
    Xu B
    Medicine (Baltimore); 2021 Jan; 100(3):e23513. PubMed ID: 33545929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the potential biomarkers for prognosis of glioblastoma via weighted gene co-expression network analysis.
    Zhang M; Zhou Z; Liu Z; Liu F; Zhao C
    PeerJ; 2022; 10():e12768. PubMed ID: 35111402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-negative matrix factorization and differential expression analyses identify hub genes linked to progression and prognosis of glioblastoma multiforme.
    Akçay S; Güven E; Afzal M; Kazmi I
    Gene; 2022 May; 824():146395. PubMed ID: 35283227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and functional characterization of lncRNAs acting as ceRNA involved in the malignant progression of glioblastoma multiforme.
    Zhang K; Li Q; Kang X; Wang Y; Wang S
    Oncol Rep; 2016 Nov; 36(5):2911-2925. PubMed ID: 27600337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AEBP1 as a potential immune-related prognostic biomarker in glioblastoma: a bioinformatic analyses.
    Liu M; Yu Y; Zhang Z; Chen Z; Chen B; Cheng Y; Wei Y; Li J; Shang H
    Ann Transl Med; 2021 Nov; 9(22):1657. PubMed ID: 34988166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Novel lncRNA Markers in Glioblastoma Multiforme and Their Clinical Significance: A Study Based on Multiple Sequencing Data.
    Li Y; Guo D
    Onco Targets Ther; 2020; 13():1087-1098. PubMed ID: 32099410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical significance of glutathione peroxidase 2 in glioblastoma multiforme.
    Guo B; Liao W; Wang S
    Transl Neurosci; 2021 Jan; 12(1):32-39. PubMed ID: 33552592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective Series of Nine Long Noncoding RNAs Associated with Survival of Patients with Glioblastoma.
    Lei B; Yu L; Jung TA; Deng Y; Xiang W; Liu Y; Qi S
    J Neurol Surg A Cent Eur Neurosurg; 2018 Nov; 79(6):471-478. PubMed ID: 29959764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
    Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
    Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.